BetterLife Pharma BETRF
OTC BETRF
$0.17 -0.01 (-5.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Gains from Sales and Divestitures (2017 - 2021)

Updated

BetterLife Pharma (BETRF) reported Gains from Sales and Divestitures of -$2.4 million for fiscal Q4 2021 (quarter ended Jan 31, 2021), compared with $987,521 a year earlier.

Analysis

BetterLife Pharma (BETRF) Gains from Sales and Divestitures (2017 - 2021) Analysis & Trends

For FY2021 (ended Jan 31, 2021), BetterLife Pharma posted Gains from Sales and Divestitures of -$601,790.

  • By fiscal year, Gains from Sales and Divestitures came in at $984,019 in FY2020 and $609,311 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 BetterLife Pharma 25.82 Mn 27.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 -2.40 Mn
Oct 31, 2017 609,311.00
API Access

BetterLife Pharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BETRF&period=max&api_key=YOUR_API_KEY